GovTwin / Companies / Square Pharmaceuticals

Square Pharmaceuticals

DSE: SQURPHARMA

Pharmaceuticals · Square Group

Square Pharmaceuticals is a leading Bangladeshi pharmaceutical manufacturer and the flagship of the Square Group, with one of the largest market capitalizations on the Dhaka Stock Exchange. It produces and markets a broad range of branded generic medicines.

Business: Manufacturing and marketing of finished pharmaceutical formulations (tablets, capsules, injectables, liquids), active pharmaceutical ingredients, and exports of medicines to multiple countries.

Market data

Market capitalisation

188,194 mn BDT

Paid-up capital

8,865 mn BDT

Outstanding shares

886,451,010

Last price

211.8 BDT

Listed

1995

Market category

A

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Domestic-market concentration in pharmaceuticals Dominance by a few large local producers shapes drug pricing and the bargaining position of the regulator (DGDA) on essential-medicine affordability. Source: analysis

TRIPS / patent transition and export competitiveness Bangladesh's graduation from least-developed-country status will end the pharmaceutical patent waiver, directly affecting a top exporter's generics model and the policy case for transition support. Source: analysis

API import dependence and forex exposure Heavy reliance on imported active ingredients ties the sector's costs to exchange-rate and reserve conditions, informing API-park and import-substitution policy. Source: analysis